Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Muraro

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|March 15, 2017
Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4<sup>+</sup> T CellsElena Muraro, Anna Merlo, Debora Martorelli, et al.
Plos One|April 29, 2016
Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell LymphomaKaty Mastorci, Elena Muraro, Elisa Pasini, et al.
Cancer Research|February 8, 2012
Retinoic acid/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targetsJessica Dal Col, Katy Mastorci, Damiana Antonia Faè, et al.
Critical Reviews in Oncology/Hematology|July 10, 2021
Cetuximab in locally advanced head and neck squamous cell carcinoma: Biological mechanisms involved in efficacy, toxicity and resistanceElena Muraro, Giuseppe Fanetti, Valentina Lupato, et al.
Frontiers in Oncology|July 25, 2022
Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and PrognosisValli De Re, Anna Rossetto, Alessandro Rosignoli, et al.
Cancers|February 5, 2020
Effect of Estrogen Receptor Status on Circulatory Immune and Metabolomics Profiles of HER2-Positive Breast Cancer Patients Enrolled for Neoadjuvant Targeted ChemotherapyAlessia Vignoli, Elena Muraro, Gianmaria Miolo, et al.
Oncotarget|May 26, 2016
Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancerGianmaria Miolo, Elena Muraro, Donatella Caruso, et al.
Cancers|February 12, 2021
Radical Hemithoracic Radiotherapy Induces Systemic Metabolomics Changes That Are Associated with the Clinical Outcome of Malignant Pleural Mesothelioma PatientsEmanuela Di Gregorio, Gianmaria Miolo, Asia Saorin, et al.
Breast (Edinburgh, Scotland)|July 11, 2022
Radiation recall dermatitis induced by COVID-19 vaccination in breast cancer patients treated with postoperative radiation therapyLorenzo Vinante, Angela Caroli, Alberto Revelant, et al.
Frontiers in Oncology|January 10, 2022
Biological Pathways Associated With the Development of Pulmonary Toxicities in Mesothelioma Patients Treated With Radical Hemithoracic Radiation Therapy: A Preliminary StudySergio Crovella, Alberto Revelant, Elena Muraro, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|March 15, 2017
Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4<sup>+</sup> T CellsElena Muraro, Anna Merlo, Debora Martorelli, et al.
Plos One|April 29, 2016
Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell LymphomaKaty Mastorci, Elena Muraro, Elisa Pasini, et al.
Cancer Research|February 8, 2012
Retinoic acid/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targetsJessica Dal Col, Katy Mastorci, Damiana Antonia Faè, et al.
Critical Reviews in Oncology/Hematology|July 10, 2021
Cetuximab in locally advanced head and neck squamous cell carcinoma: Biological mechanisms involved in efficacy, toxicity and resistanceElena Muraro, Giuseppe Fanetti, Valentina Lupato, et al.
Frontiers in Oncology|July 25, 2022
Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and PrognosisValli De Re, Anna Rossetto, Alessandro Rosignoli, et al.
Cancers|February 5, 2020
Effect of Estrogen Receptor Status on Circulatory Immune and Metabolomics Profiles of HER2-Positive Breast Cancer Patients Enrolled for Neoadjuvant Targeted ChemotherapyAlessia Vignoli, Elena Muraro, Gianmaria Miolo, et al.
Oncotarget|May 26, 2016
Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancerGianmaria Miolo, Elena Muraro, Donatella Caruso, et al.
Cancers|February 12, 2021
Radical Hemithoracic Radiotherapy Induces Systemic Metabolomics Changes That Are Associated with the Clinical Outcome of Malignant Pleural Mesothelioma PatientsEmanuela Di Gregorio, Gianmaria Miolo, Asia Saorin, et al.
Breast (Edinburgh, Scotland)|July 11, 2022
Radiation recall dermatitis induced by COVID-19 vaccination in breast cancer patients treated with postoperative radiation therapyLorenzo Vinante, Angela Caroli, Alberto Revelant, et al.
Frontiers in Oncology|January 10, 2022
Biological Pathways Associated With the Development of Pulmonary Toxicities in Mesothelioma Patients Treated With Radical Hemithoracic Radiation Therapy: A Preliminary StudySergio Crovella, Alberto Revelant, Elena Muraro, et al.
Pageof 5